Literature DB >> 25352598

Mutations in the essential arabinosyltransferase EmbC lead to alterations in Mycobacterium tuberculosis lipoarabinomannan.

Aaron Korkegian1, David M Roberts1, Rachel Blair1, Tanya Parish2.   

Abstract

The Mycobacterium tuberculosis cell wall is a complex structure essential for the viability of the organism and its interaction with the host. The glycolipid lipoarabinomannan (LAM) plays an important role in mediating host-bacteria interactions and is involved in modulation of the immune response. The arabinosyltransferase EmbC required for LAM biosynthesis is essential. We constructed recombinant strains of M. tuberculosis expressing a variety of alleles of EmbC. We demonstrated that EmbC has a functional signal peptide in M. tuberculosis. Over- or underexpression of EmbC resulted in reduced or increased sensitivity to ethambutol, respectively. The C-terminal domain of EmbC was essential for activity because truncated alleles were unable to mediate LAM production in Mycobacterium smegmatis and were unable to complement an embC deletion in M. tuberculosis. The C-terminal domain of the closely related arabinosyltransferase EmbB was unable to complement the function of the EmbC C-terminal domain. Two functional motifs were identified. The GT-C motif contains two aspartate residues essential for function in the DDX motif. The proline-rich region contains two highly conserved asparagines (Asn-638 and Asn-652). Mutation of these residues was tolerated, but loss of Asn-638 resulted in the synthesis of truncated LAM, which appeared to lack arabinose branching. All embC alleles that were incapable of complementing LAM production in M. smegmatis were not viable in M. tuberculosis, supporting the hypothesis that LAM itself is essential in M. tuberculosis.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Arabinosyltransferase; Cell Wall; Essential Gene; Ethambutol; Glycolipid; Infectious Disease; Mycobacteria; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25352598      PMCID: PMC4271206          DOI: 10.1074/jbc.M114.583112

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.

Authors:  A E Belanger; G S Besra; M E Ford; K Mikusová; J T Belisle; P J Brennan; J M Inamine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphosphatidylinositols.

Authors:  D Chatterjee; S W Hunter; M McNeil; P J Brennan
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

3.  Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.

Authors:  D Chatterjee; K Lowell; B Rivoire; M R McNeil; P J Brennan
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

4.  Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis.

Authors:  A Lemassu; M Daffé
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis.

Authors:  Jordi B Torrelles; Kay-Hooi Khoo; Peter A Sieling; Robert L Modlin; Nannan Zhang; Angela M Marques; Achim Treumann; Christopher D Rithner; Patrick J Brennan; Delphi Chatterjee
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

6.  Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.

Authors:  K Mikusová; R A Slayden; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 7.  Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.

Authors:  Volker Briken; Steven A Porcelli; Gurdyal S Besra; Laurent Kremer
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

8.  Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages.

Authors:  J Chan; X D Fan; S W Hunter; P J Brennan; B R Bloom
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.

Authors:  L Deng; K Mikusová; K G Robuck; M Scherman; P J Brennan; M R McNeil
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.

Authors:  R W Stokes; D P Speert
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

View more
  11 in total

1.  ArnT proteins that catalyze the glycosylation of lipopolysaccharide share common features with bacterial N-oligosaccharyltransferases.

Authors:  Faviola Tavares-Carreón; Yasmine Fathy Mohamed; Angel Andrade; Miguel A Valvano
Journal:  Glycobiology       Date:  2015-10-29       Impact factor: 4.313

Review 2.  The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis.

Authors:  Rainer Kalscheuer; Ainhoa Palacios; Itxaso Anso; Javier Cifuente; Juan Anguita; William R Jacobs; Marcelo E Guerin; Rafael Prados-Rosales
Journal:  Biochem J       Date:  2019-07-18       Impact factor: 3.857

3.  Identification of a Novel Mycobacterial Arabinosyltransferase Activity Which Adds an Arabinosyl Residue to α-d-Mannosyl Residues.

Authors:  Shiva Kumar Angala; Michael R McNeil; Lu Zou; Avraham Liav; Junfeng Zhang; Todd L Lowary; Mary Jackson
Journal:  ACS Chem Biol       Date:  2016-04-08       Impact factor: 5.100

4.  Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis.

Authors:  Yong Zi Tan; José Rodrigues; James E Keener; Ruixiang Blake Zheng; Richard Brunton; Brian Kloss; Sabrina I Giacometti; Ana L Rosário; Lei Zhang; Michael Niederweis; Oliver B Clarke; Todd L Lowary; Michael T Marty; Margarida Archer; Clinton S Potter; Bridget Carragher; Filippo Mancia
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

5.  Linking common non-coding RNAs of human lung cancer and M. tuberculosis.

Authors:  Debmalya Barh; Sandeep Tiwari; Ranjith N Kumavath; Preetam Ghosh; Vasco Azevedo
Journal:  Bioinformation       Date:  2018-06-30

6.  The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment.

Authors:  Manita Yimcharoen; Sukanya Saikaew; Usanee Wattananandkul; Ponrut Phunpae; Sorasak Intorasoot; Watchara Kasinrerk; Chatchai Tayapiwatana; Bordin Butr-Indr
Journal:  Infect Drug Resist       Date:  2022-02-05       Impact factor: 4.003

7.  Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients.

Authors:  Astrid Lewin; Elisabeth Kamal; Torsten Semmler; Katja Winter; Sandra Kaiser; Hubert Schäfer; Lei Mao; Patience Eschenhagen; Claudia Grehn; Jennifer Bender; Carsten Schwarz
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Improving the biotransformation efficiency of soybean phytosterols in Mycolicibacterium neoaurum by the combined deletion of fbpC3 and embC in cell envelope synthesis.

Authors:  Liang-Bin Xiong; Hao-Hao Liu; Lu Song; Miao-Miao Dong; Jie Ke; Yong-Jun Liu; Ke Liu; Ming Zhao; Feng-Qing Wang; Dong-Zhi Wei
Journal:  Synth Syst Biotechnol       Date:  2021-12-06

9.  Structural Variability of Lipoarabinomannan Modulates Innate Immune Responses within Infected Alveolar Epithelial Cells.

Authors:  Hanrui Liu; Xuwen Gui; Shixing Chen; Weizhe Fu; Xiang Li; Tingyuan Xiao; Jie Hou; Tao Jiang
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

Review 10.  Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall.

Authors:  Sarah M Batt; Christopher E Burke; Alice R Moorey; Gurdyal S Besra
Journal:  Cell Surf       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.